An enzyme given into the brain for CLN2 (Batten) disease
Cerliponase alfa
An enzyme replacement given directly into the brain's fluid spaces through an implanted device to treat CLN2 (Batten) disease.
What is Cerliponase alfa?
Cerliponase alfa is a specialist enzyme replacement medicine used to treat CLN2 disease, a form of Batten disease, in which a missing enzyme lets harmful material build up in brain cells and causes worsening problems with movement and thinking. Unlike other enzyme treatments, it has to be given directly into the fluid-filled spaces inside the brain, because it cannot reach the brain from the bloodstream. It is delivered through a small device placed in the head, on a regular basis. The main risks are infection linked to the device and reactions during the infusion.
Education and reference only. This is a plain-language guide to Cerliponase alfa — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Cerliponase alfa is an enzyme replacement therapy used to treat CLN2 disease, also known as a form of Batten disease, a rare inherited condition that mainly affects the brain. In CLN2, the body lacks a working copy of an enzyme, so harmful waste builds up in brain cells and leads to progressive loss of movement, speech and thinking skills. Because this enzyme cannot get into the brain from the bloodstream, cerliponase alfa is given directly into the fluid-filled spaces inside the brain (the ventricles) through a small device implanted in the head. It is a long-term, regular treatment given under specialist care.
How it works
In CLN2 disease, a missing enzyme means harmful waste material cannot be cleared from brain cells, so it builds up and the brain is progressively damaged. Cerliponase alfa supplies a working form of this enzyme. Crucially, enzymes given into the bloodstream cannot cross into the brain, so cerliponase alfa is instead infused directly into the brain's fluid-filled spaces, where it can reach brain cells and help clear the waste, aiming to slow the loss of abilities such as walking. Because the enzyme is used up over time, it has to be given regularly through the implanted device.
Company & origin
Originated / developed by: Specialist manufacturer.
A specialist enzyme medicine given into the fluid-filled spaces of the brain in the UK to treat CLN2 disease, a form of Batten disease.
Practical use
How to take Cerliponase alfa
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- Receive it as an infusion directly into the fluid spaces of the brain, through the implanted device, on the regular schedule your specialist team arranges.
- Have each infusion in a specialist setting where the device site and your condition can be watched closely.
- Allow time for careful checks of the device and the skin over it to catch any sign of infection early.
- Tell the team straight away about fever, headache, neck stiffness, or redness or fluid around the device, as these can signal infection.
- Keep to your regular appointments, as this is a long-term, ongoing treatment.
Weighing it up
Advantages & disadvantages of Cerliponase alfa
Advantages
- Delivers the missing enzyme directly to the brain, where it is needed, in CLN2 disease.
- Can help slow the loss of abilities such as walking compared with no treatment.
- Provides a treatment for a very rare brain condition that otherwise has few options.
Disadvantages
- Has to be given through a device implanted in the head, which carries a risk of infection.
- Can cause reactions during or after the infusion, including changes in heart rate or blood pressure.
- Needs regular hospital infusions over the long term, and the device may need attention.
Practical use
Good to know
What makes cerliponase alfa unusual is that it is given straight into the fluid-filled spaces of the brain through a device implanted under the scalp, because it cannot reach the brain through the bloodstream like other enzyme treatments. This brings two particular risks the team watches for very closely: infection related to the device, which can be serious and is a key reason infusions are carried out carefully in a specialist setting, and reactions during or after the infusion, including changes in heart rate or blood pressure. The device itself may sometimes need attention or replacement. Treatment is long term and regular, and aims to slow the loss of abilities rather than cure the condition; the specialist team explains realistic goals and monitors closely throughout.
Who should not take it / use with caution
- It is not suitable for people who have an active infection in or around the device, which must be treated first.
- People who have had a serious reaction to cerliponase alfa are reassessed carefully by the specialist team.
- It should only be given under specialist supervision by a team experienced in this device and condition.
Monitoring
- Careful checks of the device and the skin over it for any sign of infection before each infusion.
- Close observation of heart rate, blood pressure and the person during and after the infusion.
- Regular review of movement, speech and other abilities to judge how treatment is working.
Side effects
- Infection linked to the device, which can be serious and needs urgent treatment.
- Reactions during or after the infusion, including fever, irritability or changes in heart rate or blood pressure.
- Headache, vomiting or, sometimes, seizures around the time of treatment.
- Problems with the device itself, which may need attention or replacement.
Key interactions
- There are few well-established routine medicine interactions, but tell your team about all medicines.
- Medicines may be given before an infusion to reduce the chance of a reaction.
- Any sign of device infection must be reported promptly, as it affects whether infusions can go ahead.
Available as: A solution given as an infusion into the fluid-filled spaces of the brain through an implanted device.
Answers
Cerliponase alfa: frequently asked questions
What is cerliponase alfa used for?
It is an enzyme replacement therapy used to treat CLN2 disease, a form of Batten disease, by supplying a working form of the missing enzyme directly to the brain.
Why is it given into the brain?
The enzyme cannot reach the brain from the bloodstream, so it has to be given directly into the brain's fluid-filled spaces through an implanted device.
What are the main risks?
The main risks are infection linked to the device, which can be serious, and reactions during or after the infusion, so it is given carefully in a specialist setting.
How is it given?
It is given as a regular infusion through a small device implanted in the head, in a specialist hospital setting, as a long-term treatment.
Is it a cure?
No. It aims to slow the loss of abilities such as walking rather than cure the condition, and the specialist team explains realistic goals.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.